Chun-Wen Cheng

Prof. Chun-Wen Cheng


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 April 2012 in Breast Cancer Research and Treatment
Verified
Journal Article
Closed access
PDF file
CCChun-Wen Cheng
Chun-Wen Cheng
HWHsiao-Wei Wang
Hsiao-Wei Wang
CCChia-Wei Chang
Chia-Wei Chang
HCHou-Wei Chu
Hou-Wei Chu
CCCheng-You Chen
Cheng-You Chen
CSChen-Yang Shen
Chen-Yang Shen

Verified
Journal Article
Open access
PDF file
WLWen Ling Liao
Wen Ling Liao
JLJing-Yi Lin
Jing-Yi Lin
JSJia-Ching Shieh
Jia-Ching Shieh
HYHsiao-Fong Yeh
Hsiao-Fong Yeh
Yi-Hsien HsiehYi-Hsien Hsieh
Yi-Hsien Hsieh
CCChun-Wen Cheng
Chun-Wen Cheng
The anti-tumor activity of diosgenin, a new steroidal constituent present in fenugreek, on two human breast cancer cell lines, MCF-7 and Hs578T, was studied. Diosgenin treatment resulted in cell growth inhibition, cell cycle arrest, and apoptosis in concentration- and time-dependent manners in both cell lines. Western blot analyses of whole cell lysates for cell cycle proteins showed that diosgenin altered phosphorylated cyclin checkpoint1 (p-Chk1Ser345) and cyclin B expression, which resulted in G2/M phase blockade. Mechanistically, Cdc25C-Cdc2 signaling was involved in inactivating Chk1Ser345 by p53-dependence in MCF-7 cells and p21-dependence in Hs578T cells that are p53-deficient. Moreover, diosgenin induced a significant loss of the mitochondrial membrane potential in breast cancer cells, and prominently affected cell death through down-regulation of the anti-apoptotic protein, Bcl-2. This released cytochrome c and activated the caspase signaling cascade. Taken together, these findings reveal that the anti-proliferative activity of diosgenin involves the induction of G2/M phase arrest via modulating the Cdc25C-Cdc2-cyclin B pathway and mitochondria-mediated apoptosis in human breast cancer cell lines. This suggests the potential usefulness of diosgenin in treating breast cancer.

23 October 2015 in Oncotarget
Verified
Journal Article
Open access
CCChun-Wen Cheng
Chun-Wen Cheng
PCPo-Ming Chen
Po-Ming Chen
Yi-Hsien HsiehYi-Hsien Hsieh
Yi-Hsien Hsieh
CWChung-Chih Weng
Chung-Chih Weng
CCChia-Wei Chang
Chia-Wei Chang
CSChen-Yang Shen
Chen-Yang Shen
Foxo3a-mediated overexpression of microRNA-622 suppresses tumor metastasis by repressing hypoxia-inducible factor-1α in erk-responsive of lung cancer

24 February 2016 in Oncotarget
Verified
Journal Article
Open access
PDF file
CCChia-Wei Chang
Chia-Wei Chang
JYJyh-Cherng Yu
Jyh-Cherng Yu
Yi-Hsien HsiehYi-Hsien Hsieh
Yi-Hsien Hsieh
CYChung-Chin Yao
Chung-Chin Yao
JCJui-I Chao
Jui-I Chao
CCChun-Wen Cheng
Chun-Wen Cheng
MicroRNA-30a increases tight junction protein expression to suppress the epithelial-mesenchymal transition and metastasis by targeting Slug in breast cancer

1 February 2010 in Clinica Chimica Acta
Verified
Journal Article
Closed access
CCChun-Wen Cheng
Chun-Wen Cheng
JYJyh-Cherng Yu
Jyh-Cherng Yu
HWHsiao-Wei Wang
Hsiao-Wei Wang
CHChiun-Sheng Huang
Chiun-Sheng Huang
JSJia-Ching Shieh
Jia-Ching Shieh
CSChen-Yang Shen
Chen-Yang Shen

21 November 2009 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
MHMing-Shiean Hsu
Ming-Shiean Hsu
JYJyh-Cherng Yu
Jyh-Cherng Yu
HWHsiao-Wei Wang
Hsiao-Wei Wang
SCShou-Tung Chen
Shou-Tung Chen
CHChia-Ni Hsiung
Chia-Ni Hsiung
CCChun-Wen Cheng
Chun-Wen Cheng